PRIDEVIN M1

bt_bb_section_bottom_section_coverage_image
https://www.larivinpharma.com/wp-content/uploads/2024/04/PRIDEVIN-M1.jpg

Composition

Active Ingredients:

  • Metformin 500 mg (Prolonged Release)
  • Glimepiride 1 mg (SMART Tablets)

Description:
Pridevin M1 is a combination of Metformin and Glimepiride in a SMART tablet formulation designed to effectively manage type 2 diabetes mellitus. This prolonged-release combination provides continuous blood glucose control by combining the glucose-lowering effects of Metformin with the insulin-secreting stimulation of Glimepiride.

Indications:
Pridevin M1 is indicated for:

  • Management of type 2 diabetes mellitus in adults.
  • Improvement of glycemic control in patients inadequately controlled on Metformin or Glimepiride alone.
  • Adjuvant therapy for lifestyle modifications and diet to achieve better blood sugar control.

Mechanism of Action:

  • Metformin: Works by decreasing hepatic glucose production and increasing insulin sensitivity in peripheral tissues, leading to improved glucose uptake and utilization.
  • Glimepiride: A sulfonylurea that stimulates the pancreas to release more insulin, thereby lowering blood glucose levels.

Dosage and Administration:

  • The usual starting dose is one SMART tablet daily, preferably taken with the morning meal to reduce gastrointestinal side effects.
  • The dosage may be adjusted based on individual patient response and blood glucose levels, with a maximum daily dose of 2,000 mg of Metformin and 4 mg of Glimepiride.

Contraindications:

  • Hypersensitivity to Metformin, Glimepiride, or any component of the SMART tablet.
  • Severe renal impairment or significant liver dysfunction.
  • Type 1 diabetes mellitus or diabetic ketoacidosis.
  • Pregnancy and breastfeeding.

Warnings and Precautions:

  • Monitor renal function regularly due to the Metformin component.
  • Caution is required in patients with a history of hypoglycemia or those taking other antidiabetic medications.
  • Discontinue use and consult a healthcare provider if symptoms of lactic acidosis (e.g., unusual muscle pain, difficulty breathing) occur.

Side Effects:
Common side effects may include:

  • Nausea
  • Diarrhea
  • Headache
  • Dizziness

Serious side effects, although rare, may include:

  • Lactic acidosis
  • Severe hypoglycemia
  • Liver dysfunction

Drug Interactions:

  • May interact with other antidiabetic medications, corticosteroids, and diuretics.
  • Caution is advised with drugs that affect glucose metabolism or renal function.

Storage:

  • Store in a cool, dry place, away from direct sunlight.
  • Keep out of reach of children.

Packaging:

  • Available in blister packs of 10 SMART tablets.

Disclaimer:
This information is provided for educational purposes only. For personalized medical advice and treatment options, consult a healthcare professional.

https://www.larivinpharma.com/wp-content/uploads/2020/06/large_blue_triangle_04.png
https://www.larivinpharma.com/wp-content/uploads/2024/04/PRIDEVIN-M1.jpg
https://www.larivinpharma.com/wp-content/uploads/2020/04/small_blue_triangle.png
https://www.larivinpharma.com/wp-content/uploads/2020/06/large_blue_triangle_01.png
https://www.larivinpharma.com/wp-content/uploads/2023/03/larivin-pharma-footer-icon-160x160.png
No.32, First Floor, Varadharaja Swamy Nagar, Sri Krishna Nagar, Maduravoyal, Chennai, Tamil Nadu 600095

© 2023 Larivin Pharma Private Limited. All rights reserved